Compare FRMM & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | ASRT |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8M | 76.0M |
| IPO Year | 2017 | 2004 |
| Metric | FRMM | ASRT |
|---|---|---|
| Price | $4.51 | $23.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 511.2K | 421.1K |
| Earning Date | 05-26-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | $183.55 | N/A |
| Revenue Next Year | $166.48 | $12.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.76 | $0.60 |
| 52 Week High | $5.87 | $23.46 |
| Indicator | FRMM | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 86.13 |
| Support Level | $4.25 | $0.70 |
| Resistance Level | $5.55 | N/A |
| Average True Range (ATR) | 0.54 | 0.18 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 46.12 | 98.48 |
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.